# Clinical Trial for Effectiveness and Safety Evaluation of Hemodiafilter

Study · id `cardio:ct-nct06454981` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06454981](<https://clinicaltrials.gov/study/NCT06454981>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06454981

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 160 participants.

## Technical summary

Registry record NCT06454981. Randomized; no masking; primary purpose treatment. Start 2021-07-23 (actual); primary completion 2021-11-02 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 160 participants (enrolled count; ClinicalTrials.gov record NCT06454981, source copy `cardio:ctgov-nct06454981-2024-06-12`, retrieved 2026-10-26)
- Started: 2021-07-23 (actual) (ClinicalTrials.gov record NCT06454981, source copy `cardio:ctgov-nct06454981-2024-06-12`, retrieved 2026-10-26)
- Primary completion: 2021-11-02 (actual) (ClinicalTrials.gov record NCT06454981, source copy `cardio:ctgov-nct06454981-2024-06-12`, retrieved 2026-10-26)
- Completion: 2022-02-12 (actual) (ClinicalTrials.gov record NCT06454981, source copy `cardio:ctgov-nct06454981-2024-06-12`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT06454981, source copy `cardio:ctgov-nct06454981-2024-06-12`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06454981-2024-06-12`, retrieved 2026-10-26)

## The registry's words

- Brief title: Clinical Trial for Effectiveness and Safety Evaluation of Hemodiafilter
- Condition: Renal Failure Chronic
- Intervention (Device): Hemodiafilter
- Intervention (Device): Fresenius Medical Care AG & Co.KGaA
- Lead sponsor: Hangzhou Kaiyuan Suixi Medical Technology Co., Ltd
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)

## Provenance

Content hash: 8799749d704e272970abe7ec609f7bf29693a8d3df0bf58d6b81fe1a39cf021d
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
